A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Amgen Inc stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 17,030 shares of AMGN stock, worth $4.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,030
Previous 17,072 0.25%
Holding current value
$4.49 Million
Previous $5.33 Million 2.87%
% of portfolio
0.13%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $12,993 - $14,169
-42 Reduced 0.25%
17,030 $5.49 Million
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $24,961 - $30,334
95 Added 0.56%
17,072 $5.33 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $9,948 - $12,008
37 Added 0.22%
16,977 $4.83 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $14,574 - $16,442
57 Added 0.34%
16,940 $4.88 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $6,122 - $7,600
28 Added 0.17%
16,883 $4.54 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $14,998 - $17,735
70 Added 0.42%
16,855 $3.74 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $13,773 - $16,787
61 Added 0.36%
16,785 $4.06 Million
Q4 2022

Feb 21, 2023

SELL
$229.03 - $291.01 $720,070 - $914,935
-3,144 Reduced 15.82%
16,724 $4.39 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $839,929 - $947,287
-3,742 Reduced 15.85%
19,868 $4.48 Million
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $300,384 - $334,275
-1,302 Reduced 5.23%
23,610 $5.74 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $659,344 - $729,407
-3,007 Reduced 10.77%
24,912 $6.02 Million
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $113,759 - $130,187
-572 Reduced 2.01%
27,919 $6.28 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $509,235 - $596,631
2,399 Added 9.19%
28,491 $6.06 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $21,255 - $23,581
-91 Reduced 0.35%
26,092 $6.36 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $1.28 Million - $1.49 Million
-5,766 Reduced 18.05%
26,183 $6.52 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $79,195 - $94,307
-366 Reduced 1.13%
31,949 $7.35 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $7.84 Million - $9.62 Million
-39,626 Reduced 55.08%
32,315 $7.62 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $8.9 Million - $11.8 Million
48,859 Added 211.68%
71,941 $14.6 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $46,356 - $59,584
245 Added 1.07%
23,082 $5.56 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $52,058 - $62,377
-299 Reduced 1.29%
22,837 $4.42 Million
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $11.9 Million - $14 Million
-71,423 Reduced 75.53%
23,136 $4.26 Million
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $337,322 - $380,236
-1,865 Reduced 1.93%
94,559 $18 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $3 Million - $3.51 Million
-16,842 Reduced 14.87%
96,424 $18.8 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $2.64 Million - $2.98 Million
-14,271 Reduced 11.19%
113,266 $23.5 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $973,385 - $1.09 Million
5,862 Added 4.82%
127,537 $23.5 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $7.17 Million - $8.37 Million
-42,289 Reduced 25.79%
121,675 $20.7 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $62,789 - $70,155
372 Added 0.23%
163,964 $28.5 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $882,454 - $1.01 Million
-5,275 Reduced 3.12%
163,592 $30.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
140,208 Added 489.23%
168,867 $29.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
28,659
28,659 $4.36 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.